Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
Showing 1,201–1,260 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
…s and dissemination This study was reviewed and approved by the Australian Institute of Aboriginal and Torres Strait Islander Studies (Ref: REC-0397) and State Education Research and Partnerships (…
…gement in adults (≥18 years) with PHPT. MEDLINE, EMBASE and the Cochrane Central Register of Controlled Trials will be searched from inception to 5 November 2025. Eligible st…
…NE (in December 2023) and Embase (via Ovid), CINAHL (EBSCO) and Web of Science (in February 2024).Eligibility criteria Any evidence from five …
…might be a safe CRP threshold in the context of suspected EONI. University Hospital Southampton now meets British Association of Perinatal Medicine and Nationa…
…nvestigator-initiated, single-arm, phase II exploratory trial ( NCT05775796) enrolled patients with histologically confirmed, resectable cl…
…prehensive Specialized Hospital in Bahir Dar, Ethiopia, and the University of Gondar Comprehensive Specialized Hospital in Gondar, Ethiopia.Participants Adults (≥18 years) with histol…
…of HPV-positive cases was estimated using data published by the Centre for Disease Control and Prevention (CDC). A prevalence cost-of-illness, non-discounted, approach w…
…mittee of the Medical Faculty of the University of Bonn and the Medical Chamber of Nordrhein (2025–325 BO). All study procedures will adhere to relevant dat…
…ndomly selected individuals aged ≥50 years participating in the Lolland-Falster Health Study with valid frailty measurements.Outcome measures Hospital visit…
…served communities.Methods We searched MEDLINE, EMBASE, CINAHL, Cochrane and ProQuest for English language publications from 2005 to 202…
… years, 53% females) referred to the Department of Neurology at Aarhus University Hospital, Denmark, for diagnostic assessment of dementia. Enrolment star…
…ty.Methods This first-in-human, open-label, multicenter study ( NCT05162755) evaluated safety, tolerability, preliminary efficacy, pharmaco…